Type 1 University, a site that provides advanced online courses for insulin users and parents or caregivers of insulin users, is offering 2 FREE webinars in March. The free webinar topic this month is "Making the Most of Your CGM" and will be presented by Gary Scheiner MS, CDE. The webinar dates are Wednesday, March 18th and Monday, March 30th.
Things in the about diabetes section.
Is it time for the diabetes community to rally a new type of support for activity, exercise and sports that raises awareness and fosters camaraderie in our community? Historically there has been at least one such organization since 1985 when IDAA (International Diabetic Athletes Association) was formed. It changed its name to DESA (Diabetes Exercise & Sports Association) in the mid-nineties to broaden its appeal and scope. This grassroots group, composed mainly of T1’s, held annual conferences nationally and internationally and brought together those of us who believe in the commitment of being physically active as a dynamic component of our diabetes management and care. IDAA/DESA became the hallmark of diabetes and exercise. Members flourished with the sustenance of the conferences and the publication of The DESA Challenge newsletter. DESA closed its doors in 2000.
The New Year gives you a great chance to clean the slate and start over with fresh energy for managing your diabetes with insulin on a pump or injections. Some people might call this list resolutions, but we prefer other words. These are areas for you to Review and decide whether to Return, Revise or Refresh.
A provocative article on the front page of the Sunday’s New York Times (April 6, 2014) took on the high cost of diabetes care and investigated several areas of medical advancements as well as outrageous pricing. The article asks startling questions such as: Are your favorite diabetes drugs and devices relevant to your treatment?
By pooling their brightest minds and best research, ten big drug companies hope to decipher diseases in ways each hasn't been able to do on its own.
Under a five-year collaboration the ten companies together with the National Institute of Health (NIH) have agreed to share scientists, tissue and blood samples and data. The diseases that are under joint investigation are Type 2 diabetes, Alzheimer's, rheumatoid arthritis, and lupus.
As the expression goes - "you've come a long way baby" - the "you" here is diabetes which has indeed come a long, long way from the time back in 1552 BC Egypt when a physician imprinted on papyrus a condition of frequent urination.